| MCRTX | RGAEX | MCRTX / RGAEX | |
| Total Expense Ratio | 0.82 | 0.63 | 130% |
| Annual Report Gross Expense Ratio | 0.82 | 0.63 | 130% |
| Fund Existence | 13 years | 24 years | - |
| Gain YTD | 0.623 | 9.404 | 7% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 5000000 | 250 | 2,000,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 1.17B | 342B | 0% |
| Annual Yield % from dividends | 0.00 | 0.22 | - |
| Returns for 1 year | 3.09 | 5.47 | 56% |
| Returns for 3 years | 119.64 | 46.98 | 255% |
| Returns for 5 years | -41.36 | 16.97 | -244% |
| Returns for 10 years | 69.89 | 100.96 | 69% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| SAGAX | 59.55 | 0.49 | +0.83% |
| Virtus Zevenbergen Innovative Gr Stk A | |||
| AASCX | 33.00 | 0.25 | +0.76% |
| Thrivent Mid Cap Stock A | |||
| JGTTX | 39.19 | 0.17 | +0.44% |
| JPMorgan Growth Advantage R3 | |||
| SMDIX | 22.84 | 0.06 | +0.26% |
| Hartford Schroders US MidCap Opps I | |||
| CZMGX | 22.92 | 0.06 | +0.26% |
| Columbia Integrated Large Cap Gr II Inst | |||